Circadian clock, cell cycle and cancer:Circadian rhythm and cell growth regulation

Protein Reviews

Volumn 12, Issue , 2010, Pages 139-155

  Zhao, Zhaoyang ^a   Lee, Cheng Chi ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CANCER RISK; CARCINOGENESIS; CELL CYCLE REGULATION; CELL GROWTH; CIRCADIAN RHYTHM; DNA DAMAGE; GENE EXPRESSION REGULATION; GROWTH REGULATION; HOMEOSTASIS; HUMAN; LIFESTYLE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALIA; MAMMALIA; MUS; NEUROSPORA;

EID: 77953373685     PISSN: 18713025     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1262-6-6     Document Type: Review

References (105)

1. Akerstedt T et al (1984) Shift work and cardiovascular disease. Scand J Work Environ Health 10(6 Spec No):409-414
2. Stevens RG et al (1992) Electric power, pineal function, and the risk of breast cancer. FASEB J 6(3):853-860
3. Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93(20):1557-1562
4. Rafnsson V et al (2001) Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 12(2):95-101
5. Kubo T et al (2006) Prospective cohort study of the risk of prostate cancer among rotatingshift workers: findings from the Japan collaborative cohort study. Am J Epidemiol 164(6):549-555
6. Rosbash M (1995) Molecular control of circadian rhythms. Curr Opin Genet Dev 5(5):662-668
7. Iwasaki K, Thomas JH (1997) Genetics in rhythm. Trends Genet 13(3):111-115
8. Antoch MP et al (1997) Functional identification of the mouse circadian Clock gene by transgenic BAC rescue. Cell 89(4):655-667
9. King DP et al (1997) Positional cloning of the mouse circadian clock gene. Cell 89(4): 641-653
10. Sun ZS et al (1997) RIGUI, a putative mammalian ortholog of the Drosophila period gene. Cell 90(6):1003-1011
11. Hastings M, Maywood ES (2000) Circadian clocks in the mammalian brain. Bioessays 22(1):23-31
12. Fu L et al (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111(1):41-50
13. Chen-Goodspeed M, Lee CC (2007) Tumor suppression and circadian function. J Biol Rhythms 22(4):291-298
14. Gery S, Koeffler HP (2007) The role of circadian regulation in cancer. Cold Spring Harb Symp Quant Biol 72:459-464
15. Schwartz WJ, Gainer H (1977) Suprachiasmatic nucleus: use of 14C-labeled deoxyglucose uptake as a functional marker. Science 197(4308):1089-1091
16. Stephan FK, Zucker I (1972) Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci U S A 69(6):1583-1586
17. Ralph MR et al (1990) Transplanted suprachiasmatic nucleus determines circadian period. Science 247(4945):975-978
18. Buijs RM, Kalsbeek A (2001) Hypothalamic integration of central and peripheral clocks. Nat Rev Neurosci 2(7):521-526
19. Shearman LP et al (2000) Interacting molecular loops in the mammalian circadian clock. Science 288(5468):1013-1019
20. Zheng B et al (1999) The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 400(6740):169-173
21. Ko CH, Takahashi JS (2006) Molecular components of the mammalian circadian clock. Hum Mol Genet. 15 Spec No. 2:R271-R277
22. Reick M et al (2001) NPAS2: an analog of clock operative in the mammalian forebrain. Science 293(5529):506-509
23. Bertolucci C et al (2008) Evidence for an overlapping role of CLOCK and NPAS2 transcription factors in liver circadian oscillators. Mol Cell Biol 28(9):3070-3075
24. Preitner N et al (2002) The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 110(2):251-260 (Pubitemid 34876552)
25. Triqueneaux G et al (2004) The orphan receptor Rev-erbalpha gene is a target of the circadian clock pacemaker. J Mol Endocrinol 33(3):585-608
26. Sato TK et al (2004) A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 43(4):527-537
27. Guillaumond F et al (2005) Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 20(5):391-403
28. Honma S et al (2002) Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 419(6909):841-844
29. Albrecht U et al (1997) A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 91(7):1055-1064
30. DeBruyne JP, Weaver DR, Reppert SM (2007) CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock. Nat Neurosci 10(5):543-545
31. Yamamoto T et al (2004) Transcriptional oscillation of canonical clock genes in mouse peripheral tissues. BMC Mol Biol 5:18
32. Hartwell LH, Weinert TA (1989) Checkpoints: controls that ensure the order of cell cycle events. Science 246(4930):629-634
33. Lim DS et al (2000) ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404(6778):613-617
34. Kastan MB, Lim DS (2000) The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1(3):179-186
35. Niida H, Nakanishi M (2006) DNA damage checkpoints in mammals. Mutagenesis 21(1):3-9
36. Garrett MD (2001) Cell cycle control and cancer. Curr Sci 81(5):8
37. Todd R, Wong DT (1999) Oncogenes. Anticancer Res 19(6A):4729-4746
38. Sherr CJ (2004) Principles of tumor suppression. Cell 116(2):235-246
39. Stambolic V, Mak TW, Woodgett JR (1999) Modulation of cellular apoptotic potential: contributions to oncogenesis. Oncogene 18(45):6094-6103
40. Marshall CJ (1988) The ras oncogenes. J Cell Sci Suppl 10:157-169
41. Carson DA, Lois A (1995) Cancer progression and p53. Lancet 346(8981):1009-1011
42. Boulaire J, Fotedar A, Fotedar R (2000) The functions of the cdk-cyclin kinase inhibitor p21WAF1. Pathol Biol (Paris) 48(3):190-202
43. Mailand N et al (2000) Rapid destruction of human Cdc25A in response to DNA damage. Science 288(5470):1425-1429
44. Nilsson I, Hoffmann I (2000) Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res 4:107-114
45. Perry JA, Kornbluth S (2007) Cdc25 and Wee1: analogous opposites? Cell Div 2:12
46. Bischoff JR, Plowman GD (1999) The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. Trends Cell Biol 9(11):454-459
47. Zou H et al (1999) Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285(5426):418-422
48. Jin DY, Spencer F, Jeang KT (1998) Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93(1):81-91
49. Michel LS et al (2001) MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409(6818):355-359
50. Cahill DP et al (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392(6673):300-303
51. Meyn MS (1995) Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res 55(24):5991-6001
52. Liu A et al (2005) Alterations of DNA damage-response genes ATM and ATR in pyothoraxassociated lymphoma. Lab Invest 85(3):436-446
53. Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3(3):155-168
54. Hurley PJ, Bunz F (2007) ATM and ATR: components of an integrated circuit. Cell Cycle 6(4):414-417
55. Matsuoka S et al (2000) Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci U S A 97(19):10389-10394
56. Bakkenist CJ, Kastan MB (2004) Initiating cellular stress responses. Cell 118(1):9-17
57. Shiloh Y (2006) The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 31(7):402-410
58. Matsuoka S, Huang M, Elledge SJ (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282(5395):1893-1897
59. Giaccia AJ, Kastan MB (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12(19):2973-2983
60. Osborn AJ, Elledge SJ, Zou L (2002) Checking on the fork: the DNA-replication stressresponse pathway. Trends Cell Biol 12(11):509-516
61. Kumagai A, Dunphy WG (2006) How cells activate ATR. Cell Cycle 5(12):1265-1268
62. Syljuasen RG et al (2005) Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol Cell Biol 25(9): 3553-3562
63. Sweeney BMAH (1958) Woodland, rhythmic cell division in populations of gonyaulax polyedra. J Protozool 5:217-224
64. Woelfle MA et al (2004) The adaptive value of circadian clocks: an experimental assessment in cyanobacteria. Curr Biol 14(16):1481-1486
65. Scheving LE et al (1978) Circadian variation in cell division of the mouse alimentary tract, bone marrow and corneal epithelium. Anat Rec 191(4):479-486
66. Scheving LE (1981) Circadian rhythms in cell proliferation: their importance when investigating the basic mechanism of normal versus abnormal growth. Prog Clin Biol Res 59C(00):39-79
67. Panda S et al (2002) Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109(3):307-320
68. Storch KF et al (2002) Extensive and divergent circadian gene expression in liver and heart. Nature 417(6884):78-83
69. Miller BH et al (2007) Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci U S A 104(9):3342-3347
70. Grechez-Cassiau A et al (2008) The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem 283(8):4535-4542
71. Matsuo T et al (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302(5643):255-259
72. Cardone L, Sassone-Corsi P (2003) Timing the cell cycle. Nat Cell Biol 5(10):859-861
73. Barnes JW et al (2003) Requirement of mammalian Timeless for circadian rhythmicity. Science 302(5644):439-442
74. Unsal-Kacmaz K et al (2005) Coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol 25(8):3109-3116
75. Unsal-Kacmaz K et al (2007) The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement. Mol Cell Biol 27(8):3131-3142
76. Pregueiro AM et al (2006) The Neurospora checkpoint kinase 2: a regulatory link between the circadian and cell cycles. Science 313(5787):644-649
77. Gery S et al (2005) Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood 106(8):2827-2836
78. Yoon K, Smart RC (2004) C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes. Mol Cell Biol 24(24):10650-10660
79. Chen Z et al (2007) Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. Science 316(5833):1916-1919
80. Chen Z, McKnight SL (2007) A conserved DNA damage response pathway responsible for coupling the cell division cycle to the circadian and metabolic cycles. Cell Cycle 6(23):2906-2912
81. Reinberg A (1975) Circadian changes in the temperature of human beings. Bibl Radiol 6:128-139
82. Mansfield CM et al (1973) Circadian rhythm in the skin temperature of normal and cancerous breasts. Int J Chronobiol 1(3):235-243
83. Klevecz RR et al (1987) Circadian gating of S phase in human ovarian cancer. Cancer Res 47(23):6267-6271
84. Lee CC (2006) Tumor suppression by the mammalian period genes. Cancer Causes Control 17(4):525-530
85. Barlow C et al (1999) Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice. Nat Genet 21(4):359-360
86. Vassilev LT et al (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303(5659):844-848
87. Hollander MC, Fornace AJ Jr (2002) Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a. Oncogene 21(40):6228-6233
88. Ramsay G, Evan GI, Bishop JM (1984) The protein encoded by the human proto-oncogene c-myc. Proc Natl Acad Sci U S A 81(24):7742-7746
89. Prochownik EV, Li Y (2007) The ever expanding role for c-Myc in promoting genomic instability. Cell Cycle 6(9):1024-1029
90. Yang X et al (2009) Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat 117(2): 423-431
91. Hua H et al (2006) Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 97(7):589-596
92. Wood PA et al (2008) Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res 6(11):1786-1793
93. Ayyanan A et al (2006) Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci U S A 103(10):3799-3804
94. Saldanha G et al (2004) Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation. Br J Dermatol 151(1):157-164
95. Zhang J et al (2008) High expression of circadian gene mPer2 diminishes radiosensitivity of tumor cells. Cancer Biother Radiopharm 23(5):561-570
96. Gery S et al (2006) The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 22(3):375-382
97. Chen ST et al (2005) Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26(7):1241-1246
98. Zhou BP et al (2001) HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 3(11):973-982
99. Winter SL et al (2007) Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia 9(10):797-800
100. Yarden RI et al (2002) BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet 30(3):285-289
101. Chabalier-Taste C et al (2008) BRCA1 is regulated by Chk2 in response to spindle damage. Biochim Biophys Acta 1783(12):2223-2233
102. Pogue-Geile KL, Lyons-Weiler J, Whitcomb DC (2006) Molecular overlap of fly circadian rhythms and human pancreatic cancer. Cancer Lett 243(1):55-57
103. Hoffman AE et al (2008) The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res 6(9):1461-1468
104. Zhu Y et al (2008) Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat 107(3):421-425
105. Zhu Y et al (2007) Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer 120(2):432-435